STZ诱导恒河猴糖尿病动物模型的建立
作者:
作者单位:

作者简介:

朱华,副主任技师,研究方向:病理与病理生理学。E-mail:zhuh@cnilas.org。

通讯作者:

中图分类号:

基金项目:

863课题(2009ZX09503-025)。


Establishment and Evaluation of Experimental Rhesus Monkeys Diabetes Model
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的复制稳定的链脲佐菌素诱导糖尿病恒河猴动物模型。方法健康恒河猴5只,小剂量(30 mg/kg)多次静脉注射链脲佐菌素,分别在注射后2、3个月进行葡萄糖耐量实验并连续观察血糖、胰岛素、C肽的变化。连续观察12个月。结果随着时间推移,动物出现典型的糖尿病症状。3只动物的血糖静脉注射1次后持续10周稳定,另外2只分别进行了第2、3次注射。动物血糖在12个月内平稳上升、胰岛素、C肽分泌持续下降。2个月时葡萄糖耐量减低明显(P <0.01)。结论小剂量多次注射STZ后恒河猴可出现持续、稳定的糖尿病表现,可作为相关研究的动物模型。

    Abstract:

    ObjectiveTo make a reproducible diabetes mellitus model in macaques by injecting streptozotocin (STZ). Methodswe used STZ (30 mg/kg of body weight, intravenously, 3days) to five macaques. The dynamic changes of the glucose, C-peptide and insulin contents in plasma were measured for 12 months. The IVGTT were made at 2 and 3 month. ResultsThree of five monkeys became markedly hyperglycemic, 2 other monkeys received a second and third dose of STZ intravenously (30 mg/kg) after the first dose. Compared with the contents before injection,the glucose contents increased significantly while C-peptide and insulin contents reduced in plasma in macaques 1 week after streptozotocin injection(P<0.01),Diabetic monkeys also had abnormal responses to an intravenous glucose tolerance test at 2 and 3month. ConclusionThe results showed that low dose with 30 mg/kg STZ could lead to the significant changes in glucose, C-peptide and insulin content stably, indicating that macaques diabetes mellitus model was established successfully.

    参考文献
    相似文献
    引证文献
引用本文

朱华,刘颖,马春梅,黄澜,秦川. STZ诱导恒河猴糖尿病动物模型的建立[J].中国比较医学杂志,2012,22(6):53~56.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期: